Re: Pediatric ceftriaxone nephrolithiasis.
Avci
Zekai
Z
Karadag
Ahmet
A
Odemis
Ender
E
Catal
Ferhat
F
D000900:Anti-Bacterial Agents / Q000009:adverse effects* / Q000627:therapeutic use; D002443:Ceftriaxone / Q000009:adverse effects* / Q000627:therapeutic use; D002648:Child; D004305:Dose-Response Relationship, Drug; D006801:Humans; D007669:Kidney Calculi / Q000139:chemically induced*; D011446:Prospective Studies; D012307:Risk Factors
D000900:Anti-Bacterial Agents; D002443:Ceftriaxone